Radium-223 dichloride causes transient changes in natural killer cell population and cytotoxic function

References

• Abel AM, Yang C, Thakar MS, Malarkannan S. 2018. Natural killer cells: development, maturation, and clinical utilization. Front Immunol. 9:1869.
   PubMed Web of Science ®Google Scholar
• Abou DS, Ulmert D, Doucet M, Hobbs RF, Riddle RC, Thorek DL. 2016. Whole-body and microenvironmental localization of radium-223 in naive and mouse models of prostate cancer metastasis. J Natl Cancer Inst. 108(5):djv380.
   PubMedGoogle Scholar
• Barsegian V, Muller SP, Mockel D, Horn PA, Bockisch A, Lindemann M. 2017. Lymphocyte function following radium-223 therapy in patients with metastasized, castration-resistant prostate cancer. Eur J Nucl Med Mol Imaging. 44(2):242–246.
   PubMed Web of Science ®Google Scholar
• Beaulieu AM. 2021. Transcriptional and epigenetic regulation of memory NK cell responses. Immunol Rev. 300(1):125–133.
   PubMed Web of Science ®Google Scholar
• Cheda A, Wrembel-Wargocka J, Lisiak E, Nowosielska EM, Marciniak M, Janiak MK. 2004. Single low doses of X rays inhibit the development of experimental tumor metastases and trigger the activities of NK cells in mice. Radiat Res. 161(3):335–340.
   PubMed Web of Science ®Google Scholar
• Chen J, Liu X, Zeng Z, Li J, Luo Y, Sun W, Gong Y, Zhang J, Wu Q, Xie C. 2020. Immunomodulation of NK cells by ionizing radiation. Front Oncol. 10:874.
   PubMed Web of Science ®Google Scholar
• Dauer LT, Williamson MJ, Humm J, O'Donoghue J, Ghani R, Awadallah R, Carrasquillo J, Pandit-Taskar N, Aksnes AK, Biggin C, et al. 2014. Radiation safety considerations for the use of ²²³RaCl₂ DE in men with castration-resistant prostate cancer. Health Phys. 106(4):494–504.
   PubMed Web of Science ®Google Scholar
• Demaria S, Coleman CN, Formenti SC. 2016. Radiotherapy: changing the game in immunotherapy. Trends Cancer. 2(6):286–294.
   PubMed Web of Science ®Google Scholar
• Deutsch E, Chargari C, Galluzzi L, Kroemer G. 2019. Optimising efficacy and reducing toxicity of anticancer radioimmunotherapy. Lancet Oncol. 20(8):e452–e463.
   PubMed Web of Science ®Google Scholar
• Diegeler S, Hellweg CE. 2017. Intercellular communication of tumor cells and immune cells after exposure to different ionizing radiation qualities. Front Immunol. 8:664.
   PubMed Web of Science ®Google Scholar
• Dondossola E, Casarin S, Paindelli C, De-Juan-Pardo EM, Hutmacher DW, Logothetis CJ, Friedl P. 2019. Radium 223-mediated zonal cytotoxicity of prostate cancer in bone. J Natl Cancer Inst. 111(10):1042–1050.
   PubMedGoogle Scholar
• Durbin PW, Asling CW, Jeung N, Williams MH, Post J, Johnston ME, Hamiilton JG. 1958. The metabolism and toxicity of radium-223 in rats. Berkeley (CA): University of California.
   Google Scholar
• Eckert F, Schilbach K, Klumpp L, Bardoscia L, Sezgin EC, Schwab M, Zips D, Huber SM. 2018. Potential role of CXCR4 targeting in the context of radiotherapy and immunotherapy of cancer. Front Immunol. 9:3018.
   PubMed Web of Science ®Google Scholar
• Formenti SC, Demaria S. 2013. Combining radiotherapy and cancer immunotherapy: a paradigm shift. J Natl Cancer Inst. 105(4):256–265.
   PubMed Web of Science ®Google Scholar
• Formenti SC, Lee P, Adams S, Goldberg JD, Li X, Xie MW, Ratikan JA, Felix C, Hwang L, Faull KF, et al. 2018. Focal irradiation and systemic TGFβ blockade in metastatic breast cancer. Clin Cancer Res. 24(11):2493–2504.
   PubMed Web of Science ®Google Scholar
• Friedman J, Padget M, Lee J, Schlom J, Hodge J, Allen C. 2019. Direct and antibody-dependent cell-mediated cytotoxicity of head and neck squamous cell carcinoma cells by high-affinity natural killer cells. Oral Oncol. 90:38–44.
   PubMed Web of Science ®Google Scholar
• Garg S, Boerma M, Wang J, Fu Q, Loose DS, Kumar KS, Hauer-Jensen M. 2010. Influence of sublethal total-body irradiation on immune cell populations in the intestinal mucosa. Radiat Res. 173(4):469–478.
   PubMed Web of Science ®Google Scholar
• Gomez V, Mustapha R, Ng K, Ng T. 2020. Radiation therapy and the innate immune response: clinical implications for immunotherapy approaches. Br J Clin Pharmacol. 86(9):1726–1735.
   PubMed Web of Science ®Google Scholar
• Gregoire C, Chasson L, Luci C, Tomasello E, Geissmann F, Vivier E, Walzer T. 2007. The trafficking of natural killer cells. Immunol Rev. 220:169–182.
   PubMed Web of Science ®Google Scholar
• Henriksen G, Fisher DR, Roeske JC, Bruland OS, Larsen RH. 2003. Targeting of osseous sites with alpha-emitting 223Ra: comparison with the beta-emitter 89Sr in mice. J Nucl Med. 44(2):252–259.
   PubMed Web of Science ®Google Scholar
• Heylmann D, Rodel F, Kindler T, Kaina B. 2014. Radiation sensitivity of human and murine peripheral blood lymphocytes, stem and progenitor cells. Biochim Biophys Acta. 1846(1):121–129.
   PubMed Web of Science ®Google Scholar
• Hochman PS, Cudkowicz G, Dausset J. 1978. Decline of natural killer cell activity in sublethally irradiated mice. J Natl Cancer Inst. 61(1):265–268.
   PubMedGoogle Scholar
• Howell RW, Goddu SM, Narra VR, Fisher DR, Schenter RE, Rao DV. 1997. Radiotoxicity of gadolinium-148 and radium-223 in mouse testes: relative biological effectiveness of alpha-particle emitters in vivo. Radiat Res. 147(3):342–348.
   PubMed Web of Science ®Google Scholar
• ICRU. 2016. ICRU Report 93: prescribing, recording, and reporting light ion beam therapy. J ICRU. 16(1–2):1–211.
   Google Scholar
• Jamieson AM, Isnard P, Dorfman JR, Coles MC, Raulet DH. 2004. Turnover and proliferation of NK cells in steady state and lymphopenic conditions. J Immunol. 172(2):864–870.
   PubMed Web of Science ®Google Scholar
• Jiang W, Ulmert D, Simons BW, Abou DS, Thorek DLJ. 2018. The impact of age on radium-223 distribution and an evaluation of molecular imaging surrogates. Nucl Med Biol. 62–63:1–8.
   PubMed Web of Science ®Google Scholar
• Kajioka EH, Andres ML, Li J, Mao XW, Moyers MF, Nelson GA, Slater JM, Gridley DS. 2000. Acute effects of whole-body proton irradiation on the immune system of the mouse. Radiat Res. 153(5 Pt 1):587–594.
   PubMed Web of Science ®Google Scholar
• Karre K, Ljunggren HG, Piontek G, Kiessling R. 1986. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature. 319(6055):675–678.
   PubMed Web of Science ®Google Scholar
• Leung CN, Canter BS, Rajon D, Back TA, Fritton JC, Azzam EI, Howell RW. 2020. Dose-dependent growth delay of breast cancer xenografts in the bone marrow of mice treated with 223Ra: the role of bystander effects and their potential for therapy. J Nucl Med. 61(1):89–95.
   PubMed Web of Science ®Google Scholar
• Liu S, Galat V, Galat Y, Lee YKA, Wainwright D, Wu J. 2021. NK cell-based cancer immunotherapy: from basic biology to clinical development. J Hematol Oncol. 14(1):7.
   PubMed Web of Science ®Google Scholar
• Michel T, Poli A, Domingues O, Mauffray M, Theresine M, Brons NH, Hentges F, Zimmer J. 2012. Mouse lung and spleen natural killer cells have phenotypic and functional differences, in part influenced by macrophages. PLoS One. 7(12):e51230.
   PubMed Web of Science ®Google Scholar
• Miller SC. 1982. Production and renewal of murine natural killer cells in the spleen and bone marrow. J Immunol. 129(5):2282–2286.
   PubMed Web of Science ®Google Scholar
• Navarro-Martin A, Galiana IL, Berenguer Frances MA, Cacicedo J, Canas Cortes R, Comas Anton S, Padrones Sanchez S, Bolivar Cuevas S, Parry R, Guedea Edo F. 2018. Preliminary study of the effect of Stereotactic Body Radiotherapy (SBRT) on the immune system in lung cancer patients unfit for surgery: immunophenotyping analysis. Int J Mol Sci. 19(12):3963.
   PubMed Web of Science ®Google Scholar
• Parker C, Nilsson S, Heinrich D, Helle SI, O'Sullivan JM, Fossa SD, Chodacki A, Wiechno P, Logue J, Seke M, et al. 2013. Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med. 369(3):213–223.
   PubMed Web of Science ®Google Scholar
• Plowman PN. 1983. The effects of conventionally fractionated, extended portal radiotherapy on the human peripheral blood count. Int J Radiat Oncol Biol Phys. 9(6):829–839.
   PubMed Web of Science ®Google Scholar
• Seki H, Kanegane H, Iwai K, Konno A, Ohta K, Yachie A, Taniguchi N, Miyawaki T. 1994. Ionizing radiation induces apoptotic cell death in human TcR-gamma/delta + T and natural killer cells without detectable p53 protein. Eur J Immunol. 24(11):2914–2917.
   PubMed Web of Science ®Google Scholar
• Sonn CH, Choi JR, Kim TJ, Yu YB, Kim K, Shin SC, Park GH, Shirakawa T, Kim HS, Lee KM. 2012. Augmentation of natural cytotoxicity by chronic low-dose ionizing radiation in murine natural killer cells primed by IL-2. J Radiat Res. 53(6):823–829.
   PubMed Web of Science ®Google Scholar
• Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, Yokoyama WM, Ugolini S. 2011. Innate or adaptive immunity? The example of natural killer cells. Science. 331(6013):44–49.
   PubMed Web of Science ®Google Scholar
• Vogel B, Tennert K, Full F, Ensser A. 2014. Efficient generation of human natural killer cell lines by viral transformation. Leukemia. 28(1):192–195.
   PubMed Web of Science ®Google Scholar
• Yang G, Kong Q, Wang G, Jin H, Zhou L, Yu D, Niu C, Han W, Li W, Cui J. 2014. Low-dose ionizing radiation induces direct activation of natural killer cells and provides a novel approach for adoptive cellular immunotherapy. Cancer Biother Radiopharm. 29(10):428–434.
   PubMed Web of Science ®Google Scholar
• Yoon MS, Pham CT, Phan MT, Shin DJ, Jang YY, Park MH, Kim SK, Kim S, Cho D. 2016. Irradiation of breast cancer cells enhances CXCL16 ligand expression and induces the migration of natural killer cells expressing the CXCR6 receptor. Cytotherapy. 18(12):1532–1542.
   PubMed Web of Science ®Google Scholar
• Yoshida K, Kaneta T, Takano S, Sugiura M, Kawano T, Hino A, Yamamoto T, Shizukuishi K, Kaneko M, Zurth C, et al. 2016. Pharmacokinetics of single dose radium-223 dichloride (BAY 88-8223) in Japanese patients with castration-resistant prostate cancer and bone metastases. Ann Nucl Med. 30(7):453–460.
   PubMed Web of Science ®Google Scholar
• Zarcone D, Tilden AB, Lane VG, Grossi CE. 1989. Radiation sensitivity of resting and activated nonspecific cytotoxic cells of T lineage and NK lineage. Blood. 73(6):1615–1621.
   PubMed Web of Science ®Google Scholar
• Zhou L, Zhang X, Li H, Niu C, Yu D, Yang G, Liang X, Wen X, Li M, Cui J. 2018. Validating the pivotal role of the immune system in low-dose radiation-induced tumor inhibition in Lewis lung cancer-bearing mice. Cancer Med. 7(4):1338–1348.
   PubMed Web of Science ®Google Scholar
• Zingoni A, Molfetta R, Fionda C, Soriani A, Paolini R, Cippitelli M, Cerboni C, Santoni A. 2018. NKG2D and its ligands: “One for All, All for One”. Front Immunol. 9:476.
   PubMed Web of Science ®Google Scholar